RECOVER will probably be the largest U.S. trial of its kind, says Dr. Kristine Erlandson, the infectious disease specialist who leads the study’s Colorado site.
Critical-care medicine specialist Dr. Sarah Jolley, medical director of the UCHealth Post-COVID Clinic, is co-author of a forthcoming RECOVER-based study that assigns many of the long COVID-related maladies into five domains, she says. They include:
- ME/CFS including post-exertional malaise (PEM).
- Dysautonomia and POTS.
- Neurocognitive symptoms (such as “brain fog”).
- Cardiopulmonary exercise intolerance.
- Persistent olfactory (related to the ability to smell) problems.
